Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Leveraging the Peritoneum as a New Diuretic Strategy for Heart Failure.

Toto RD.

Circulation. 2020 Mar 31;141(13):1054-1056. doi: 10.1161/CIRCULATIONAHA.120.045484. Epub 2020 Mar 30. No abstract available.

PMID:
32223680
2.

Urine Klotho Is Lower in Critically Ill Patients With Versus Without Acute Kidney Injury and Associates With Major Adverse Kidney Events.

Neyra JA, Li X, Mescia F, Ortiz-Soriano V, Adams-Huet B, Pastor J, Hu MC, Toto RD, Moe OW.

Crit Care Explor. 2019 Jun 26;1(6):e0016. doi: 10.1097/CCE.0000000000000016. eCollection 2019 Jun.

PMID:
32166260
3.

Urine Klotho Is Lower in Critically Ill Patients With Versus Without Acute Kidney Injury and Associates With Major Adverse Kidney Events.

Neyra JA, Li X, Mescia F, Ortiz-Soriano V, Adams-Huet B, Pastor J, Hu MC, Toto RD, Moe OW; Klotho and Acute Kidney Injury (KLAKI) Study Group.

Crit Care Explor. 2019 Jun;1(6). doi: 10.1097/cce.0000000000000016.

4.

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.

Heerspink HJL, Stefansson BV, Chertow GM, Correa-Rotter R, Greene T, Hou FF, Lindberg M, McMurray J, Rossing P, Toto R, Langkilde AM, Wheeler DC; DAPA-CKD Investigators.

Nephrol Dial Transplant. 2020 Feb 1;35(2):274-282. doi: 10.1093/ndt/gfz290.

5.

Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization.

Desai NR, Rowan CG, Alvarez PJ, Fogli J, Toto RD.

PLoS One. 2020 Jan 7;15(1):e0226844. doi: 10.1371/journal.pone.0226844. eCollection 2020.

6.

Inflammation and Response to Sertraline Treatment in Patients With CKD and Major Depression.

Gregg LP, Carmody T, Le D, Toto RD, Trivedi MH, Hedayati SS.

Am J Kidney Dis. 2020 Mar;75(3):457-460. doi: 10.1053/j.ajkd.2019.09.007. Epub 2019 Dec 19. No abstract available.

PMID:
31866226
7.

The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis.

Scholtes RA, van Raalte DH, Correa-Rotter R, Toto RD, Heerspink HJL, Cain V, Sjöström CD, Sartipy P, Stefánsson BV.

Diabetes Obes Metab. 2020 Apr;22(4):549-556. doi: 10.1111/dom.13923. Epub 2019 Dec 14.

8.

Extravascular Lung Water Assessment by Ultrasound to Guide Dry Weight Changes: Ready for Prime Time?

Agarwal R, Toto RD, Weir MR.

Am J Kidney Dis. 2020 Jan;75(1):1-3. doi: 10.1053/j.ajkd.2019.09.004. Epub 2019 Nov 12. No abstract available.

PMID:
31732236
9.

Kidney Tubular Damage and Functional Biomarkers in Acute Kidney Injury Following Cardiac Surgery.

Neyra JA, Hu MC, Minhajuddin A, Nelson GE, Ahsan SA, Toto RD, Jessen ME, Moe OW, Fox AA.

Kidney Int Rep. 2019 May 18;4(8):1131-1142. doi: 10.1016/j.ekir.2019.05.005. eCollection 2019 Aug.

10.

Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.

Ku E, Sarnak MJ, Toto R, McCulloch CE, Lin F, Smogorzewski M, Hsu CY.

J Am Heart Assoc. 2019 Aug 20;8(16):e012749. doi: 10.1161/JAHA.119.012749. Epub 2019 Aug 14.

11.

Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: A post hoc analysis of 10 randomized, placebo-controlled trials.

Toto RD, Goldenberg R, Chertow GM, Cain V, Stefánsson BV, Sjöström CD, Sartipy P.

J Diabetes Complications. 2019 Oct;33(10):107402. doi: 10.1016/j.jdiacomp.2019.06.007. Epub 2019 Jul 2.

PMID:
31375422
12.

Effects of Bardoxolone Methyl on Magnesium in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.

Rizk DV, Silva AL, Pergola PE, Toto R, Warnock DG, Chin MP, Goldsberry A, O'Grady M, Meyer CJ, McCullough PA.

Cardiorenal Med. 2019;9(5):316-325. doi: 10.1159/000500612. Epub 2019 Jun 6.

13.

Count me in: using a patient portal to minimize implicit bias in clinical research recruitment.

Kannan V, Wilkinson KE, Varghese M, Lynch-Medick S, Willett DL, Bosler TA, Chu L, Gates SI, Holbein MEB, Willett MM, Reimold SC, Toto RD.

J Am Med Inform Assoc. 2019 Aug 1;26(8-9):703-713. doi: 10.1093/jamia/ocz038.

PMID:
31081898
14.

Low serum magnesium is associated with faster decline in kidney function: the Dallas Heart Study experience.

Ferrè S, Li X, Adams-Huet B, Maalouf NM, Sakhaee K, Toto RD, Moe OW, Neyra JA.

J Investig Med. 2019 Aug;67(6):987-994. doi: 10.1136/jim-2018-000966. Epub 2019 Mar 2.

15.

Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.

McGuire DK, Alexander JH, Johansen OE, Perkovic V, Rosenstock J, Cooper ME, Wanner C, Kahn SE, Toto RD, Zinman B, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, Marx N; CARMELINA Investigators.

Circulation. 2019 Jan 15;139(3):351-361. doi: 10.1161/CIRCULATIONAHA.118.038352.

PMID:
30586723
16.

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA.

Am J Kidney Dis. 2019 Mar;73(3):309-315. doi: 10.1053/j.ajkd.2018.10.006. Epub 2018 Dec 19.

17.

Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network.

Visweswaran S, Becich MJ, D'Itri VS, Sendro ER, MacFadden D, Anderson NR, Allen KA, Ranganathan D, Murphy SN, Morrato EH, Pincus HA, Toto R, Firestein GS, Nadler LM, Reis SE.

JAMIA Open. 2018 Oct;1(2):147-152. doi: 10.1093/jamiaopen/ooy033. Epub 2018 Aug 21.

18.

Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic Patients.

Neyra JA, Mescia F, Li X, Adams-Huet B, Yessayan L, Yee J, Toto RD, Moe OW.

Kidney Int Rep. 2018 Jul 29;3(6):1344-1353. doi: 10.1016/j.ekir.2018.07.016. eCollection 2018 Nov.

19.

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.

Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK; CARMELINA Investigators.

JAMA. 2019 Jan 1;321(1):69-79. doi: 10.1001/jama.2018.18269.

20.

A Modern Epidemic: Increasing Pediatric Emergency Department Visits and Admissions for Headache.

Perry MC, Yaeger SK, Toto RL, Suresh S, Hickey RW.

Pediatr Neurol. 2018 Dec;89:19-25. doi: 10.1016/j.pediatrneurol.2018.07.015. Epub 2018 Aug 4.

PMID:
30343832
21.

2018 American Society of Consultant Pharmacists Annual Meeting & Exhibition.

Bridgeman M, Prete D, Rolston N, Abazia D, Sturgill M, Finn L, Summers D, Marvanova M, Henkel P, Thompson J, Dewey M, Friesner D, Marvanova M, Alessi C, Cuellar L, Yamagishi L, O'Neil C, Erickson O, Mazzei K, Kamal K, Early N, Bainter B, Hanson L, Schmitz E, Loomis A, Norberto M, Hume A, Meyer M, Batra R, Likar D, Enguidanos S, Liu C, Kotansky B, Fisher A, Ruby CM, Pruskowski J, Karim SNA, Yong BSW, Alessi C, Cuellar L, Slattum P, Crouse E, Delafuente J, Donohoe K, Ogbonna K, Peron E, Powers K, Price E, Zimmerman K, Rahim S, Gendron T, Slattum P, Donohoe K, Cho C, Zimmerman K, Crouse E, Peron E, Powers K, Price E, Slattum P, Donohoe K, Elliott L, Minter C, Morin M, Marshall L, Stevens G, Cordaro C, Hill M, Nagy K, Kroustos KR, Sobota KF, Mahan R, Bailey T, Ioannou K, Mansour D, Thompson T, Chatellier K, Schwenk A, Ruby C, Chen TS, Li S, James M, Spilios M, Leschak A, Levine A, Forgette S, Oluigbo N, Szollosi D, Avalime D, Weaver SB, Maneno M, Ettienne E, Yi JY, Hart L, Gray S, Ozalas S, Miller K, Dave R, Bork J, Emmelhainz J, Adams K, Postolski J, Willoughby M, Feldman E, Braham K, Miller C, Barbagallo D, Seabury R, Noviasky J, Alessi C, Cuellar L, Dabhi J, Bartlett D, Le T, Simoni-Wastila L, Kuzucan A, Simoni-Wastila L, Le T, Park S, Simoni-Wastila L, Le T, Park S, Choi M, Simoni-Wastila L, Park S, Le T, Choi M, Simoni-Wastila L, Khokhar B, Choi M, Le T, Simoni-Wastila L, Brody P, Hejna M, Mason J, Graham M, Micceri J, Lypska R, Quinn B, Wilson H, Wahler R, Aloyo M, Tomm V, Hill A, Obringer A, Butterfoss K, Blak J, Balcer R, Boza J, Foster A, Shafique E, Kleven C, Wigle P, Brown B, Alessi C, Cuellar L, Meyer K, Mobley-Bukstein W, Singh H, Perez E, Mira AE, Kuehner W, Czechowski L, Cook H, Brandt N, Parson J, Fornaro R, Brandt N, Claeys K, Zarowitz B, Mansour D, McFadden C, Simpkins S, Ojowa F, Klutts A, Holmes S, Smith E, Cornman JR, Doran K, Resnick B, Brandt N, Umeozulu C, Williams A, Brandt N, Hennawi G, Thomas D, Gerber DK, Meyer K, Sharma K, Cooke C, Howard A, Chater R, Vogler A, Brandt N, Kennett-Hayes K, Elliott L, Engelbert J, Hargrave E, Bambico C, Patel K, Warriner C, Slattum P, Desai NR, Rowan CG, Alvarez P, Fogli J, Toto RD, Desai NR, Alvarez P, Fogli J, Reed P, Owens MK, Greden JF, Rothschild AJ, Zandy S, Thase M, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Li J, Gilbert A, Burns L, Jablonski M, Dechairo B, Parikh S, Donohue J, Feldman G, Sethi S, Barnes C, Pendyala S, Bourdet D, Ferguson G, Barnes C, Pendyala S, Crater G, Fogli J, Mayo M, Gross C, Miyawa J, Ono R, Woods S, Garza D, Panov N, Fogli J, Moran E, Sabesan V, Wertman J, Ngim K.

Consult Pharm. 2017 Oct 1;33(10):572-608.

PMID:
30322434
22.

Defining Hypertension: Role of New Trials and Guidelines.

Toto RD.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1578-1580. doi: 10.2215/CJN.05350418. Epub 2018 Sep 21. No abstract available.

23.

Effects of sodium glucose co-transporter 2 inhibitors on the kidney.

de Albuquerque Rocha N, Neeland IJ, McCullough PA, Toto RD, McGuire DK.

Diab Vasc Dis Res. 2018 Sep;15(5):375-386. doi: 10.1177/1479164118783756. Epub 2018 Jul 2. Review.

PMID:
29963920
24.

Experiential Communications Curriculum to Improve Resident Preparedness When Responding to Discriminatory Comments in the Workplace.

March C, Walker LW, Toto RL, Choi S, Reis EC, Dewar S.

J Grad Med Educ. 2018 Jun;10(3):306-310. doi: 10.4300/JGME-D-17-00913.1.

25.

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk.

Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK; CARMELINA® investigators.

Cardiovasc Diabetol. 2018 Mar 14;17(1):39. doi: 10.1186/s12933-018-0682-3.

26.

Bardoxolone-the Phoenix?

Toto RD.

J Am Soc Nephrol. 2018 Feb;29(2):360-361. doi: 10.1681/ASN.2017121317. Epub 2018 Jan 25. No abstract available.

27.

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.

Mc Causland FR, Claggett B, Pfeffer MA, Burdmann EA, Eckardt KU, Levey AS, McMurray JJV, Remuzzi G, Singh AK, Solomon SD, Toto RD, Parfrey P.

Am J Nephrol. 2017;46(6):488-497. doi: 10.1159/000485326. Epub 2017 Dec 14.

28.

Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.

Hedayati SS, Gregg LP, Carmody T, Jain N, Toups M, Rush AJ, Toto RD, Trivedi MH.

JAMA. 2017 Nov 21;318(19):1876-1890. doi: 10.1001/jama.2017.17131.

29.

Association of serum magnesium with all-cause mortality in patients with and without chronic kidney disease in the Dallas Heart Study.

Ferrè S, Li X, Adams-Huet B, Maalouf NM, Sakhaee K, Toto RD, Moe OW, Neyra JA.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1389-1396. doi: 10.1093/ndt/gfx275.

30.

Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.

Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK; SPRINT Research Group.

Ann Intern Med. 2017 Sep 19;167(6):375-383. doi: 10.7326/M16-2966. Epub 2017 Sep 5.

PMID:
28869987
31.

Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.

Webb DJ, Coll B, Heerspink HJL, Andress D, Pritchett Y, Brennan JJ, Houser M, Correa-Rotter R, Kohan D, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Busch R, Pergola P, Parving HH, de Zeeuw D.

Drugs R D. 2017 Sep;17(3):441-448. doi: 10.1007/s40268-017-0201-0.

32.

SGLT-2 Inhibition: A Potential New Treatment for Diabetic Kidney Disease?

Toto RD.

Nephron. 2017;137(1):64-67. doi: 10.1159/000450895. Epub 2017 Jul 26. Review.

33.

Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial.

Groop PH, Cooper ME, Perkovic V, Hocher B, Kanasaki K, Haneda M, Schernthaner G, Sharma K, Stanton RC, Toto R, Cescutti J, Gordat M, Meinicke T, Koitka-Weber A, Thiemann S, von Eynatten M.

Diabetes Obes Metab. 2017 Nov;19(11):1610-1619. doi: 10.1111/dom.13041. Epub 2017 Jul 31.

34.

Transition to Independence: Characteristics and Outcomes of Mentored Career Development (KL2) Scholars at Clinical and Translational Science Award Institutions.

Sweeney C, Schwartz LS, Toto R, Merchant C, Fair AS, Gabrilove JL; CTSA Mentored-to-Independent Investigator Transition Working Group.

Acad Med. 2017 Apr;92(4):556-562. doi: 10.1097/ACM.0000000000001473.

35.

Serum Potassium and Cardiovascular Outcomes: The Highs and the Lows.

Toto RD.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):220-221. doi: 10.2215/CJN.00030117. Epub 2017 Jan 31. No abstract available.

36.

The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

Pena MJ, de Zeeuw D, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Kohan DE, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, Sharma S, Corringham T, Sharma K, Heerspink HJL.

Diabetes Obes Metab. 2017 May;19(5):749-753. doi: 10.1111/dom.12864. Epub 2017 Feb 22.

PMID:
28019071
37.

Comparison of exposure response relationship of atrasentan between North American and Asian populations.

Heerspink HJ, Makino H, Andress D, Brennan JJ, Correa-Rotter R, Coll B, Davis JW, Idler K, Kohan DE, Liu M, Perkovic V, Remuzzi G, Tobe SW, Toto R, Parving HH, de Zeeuw D.

Diabetes Obes Metab. 2017 Apr;19(4):545-552. doi: 10.1111/dom.12851. Epub 2017 Jan 27.

PMID:
27981738
38.

Extracellular Volume Overload and Increased Vasoconstriction in Patients With Recurrent Intradialytic Hypertension.

Van Buren PN, Zhou Y, Neyra JA, Xiao G, Vongpatanasin W, Inrig J, Toto R.

Kidney Blood Press Res. 2016;41(6):802-814. doi: 10.1159/000450565. Epub 2016 Nov 11.

39.

C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Mc Causland FR, Claggett B, Burdmann EA, Eckardt KU, Kewalramani R, Levey AS, McMurray JJ, Parfrey P, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA.

Am J Kidney Dis. 2016 Dec;68(6):873-881. doi: 10.1053/j.ajkd.2016.07.022. Epub 2016 Sep 16.

40.

BP Control and Long-Term Risk of ESRD and Mortality.

Ku E, Gassman J, Appel LJ, Smogorzewski M, Sarnak MJ, Glidden DV, Bakris G, Gutiérrez OM, Hebert LA, Ix JH, Lea J, Lipkowitz MS, Norris K, Ploth D, Pogue VA, Rostand SG, Siew ED, Sika M, Tisher CC, Toto R, Wright JT Jr, Wyatt C, Hsu CY.

J Am Soc Nephrol. 2017 Feb;28(2):671-677. doi: 10.1681/ASN.2016030326. Epub 2016 Aug 11.

41.

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy.

Srivastava A, Adams-Huet B, Vega GL, Toto RD.

J Investig Med. 2016 Aug;64(6):1102-8. doi: 10.1136/jim-2016-000102. Epub 2016 Jul 7.

42.

Cumulative Fluid Balance and Mortality in Septic Patients With or Without Acute Kidney Injury and Chronic Kidney Disease.

Neyra JA, Li X, Canepa-Escaro F, Adams-Huet B, Toto RD, Yee J, Hedayati SS; Acute Kidney Injury in Critical Illness Study Group.

Crit Care Med. 2016 Oct;44(10):1891-900. doi: 10.1097/CCM.0000000000001835.

43.

APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.

Freedman BI, Gadegbeku CA, Bryan RN, Palmer ND, Hicks PJ, Ma L, Rocco MV, Smith SC, Xu J, Whitlow CT, Wagner BC, Langefeld CD, Hawfield AT, Bates JT, Lerner AJ, Raj DS, Sadaghiani MS, Toto RD, Wright JT Jr, Bowden DW, Williamson JD, Sink KM, Maldjian JA, Pajewski NM, Divers J.

Kidney Int. 2016 Aug;90(2):440-449. doi: 10.1016/j.kint.2016.04.027. Epub 2016 Jun 22.

44.

Neck Pain in a 12-Year-Old Female: An Unusual Diagnosis.

Toto RL, Zuckerbraun NS, Manole MD.

J Emerg Med. 2016 Aug;51(2):e15-8. doi: 10.1016/j.jemermed.2016.04.002. Epub 2016 Jun 1.

PMID:
27262734
45.

Comparison of Ambulatory Blood Pressure Patterns in Patients With Intradialytic Hypertension and Hemodialysis Controls.

Hompesch C, Ma TW, Neyra JA, Ripley L, Xiao G, Inrig J, Toto R, Van Buren PN.

Kidney Blood Press Res. 2016;41(3):240-9. doi: 10.1159/000443427. Epub 2016 Apr 22.

46.

Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease.

Jain N, Li X, Adams-Huet B, Sarode R, Toto RD, Banerjee S, Hedayati SS.

Am J Cardiol. 2016 Feb 15;117(4):656-663. doi: 10.1016/j.amjcard.2015.11.029. Epub 2015 Dec 7.

47.

Transplantation: The role of RAAS blockade in kidney transplantation.

Toto RD.

Nat Rev Nephrol. 2016 Mar;12(3):129-31. doi: 10.1038/nrneph.2015.201. Epub 2015 Dec 14. No abstract available.

48.

Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT.

Chertow GM, Beddhu S, Lewis JB, Toto RD, Cheung AK.

J Am Soc Nephrol. 2016 Jan;27(1):40-3. doi: 10.1681/ASN.2015101125. Epub 2015 Nov 9.

49.

Dipstick albuminuria and acute kidney injury recovery in critically ill septic patients.

Neyra JA, Li X, Yessayan L, Adams-Huet B, Yee J, Toto RD; Acute Kidney Injury in Critical Illness Study Group.

Nephrology (Carlton). 2016 Jun;21(6):512-8. doi: 10.1111/nep.12637.

PMID:
26421662
50.

Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators.

Yin HL, Gabrilove J, Jackson R, Sweeney C, Fair AM, Toto R; Clinical and Translational Science Award “Mentored to Independent Investigator Working Group Committee.

Acad Med. 2015 Jul;90(7):861-5. doi: 10.1097/ACM.0000000000000758.

Supplemental Content

Support Center